News
Researchers identify new genes predisposing to colorectal polyposis
A group from IDIBELL, the Catalan Institute of Oncology and CIBERONC has identified new genes predisposing to different types of polyposis which, if confirmed, could determine the clinical management of carriers.
The Generalitat recognizes 32 IDIBELL groups as Consolidated or Emerging Research Groups
The Agency for the Management of University and Research Grants (AGAUR) has published this week the final resolution of the call for grants to support the activities of research groups from universities, centers and foundations. In this year’s call, 32 IDIBELL groups have been recognized as Consolidated or Emerging Research Groups, of which 19 will receive funding.
Curiosity or pleasure, what comes first when we listen to a song?
The research group on Cognition and Brain Plasticity from IDIBELL and the UB answered this question with an experiment in the Milan auditorium, with the Milan orchestra and 1,000 members of the public as study participants.
Researchers generate a stem cell-based model to study an ultra-rare disease that causes childhood parkinsonism
Researchers from the Bellvitge Biomedical Research Institute (IDIBELL), the Sant Joan de Déu Research Institute (IRSJD), Sant Pau Research Institute (IIB Sant Pau) and the UB generated the first model of this disease that reproduce patients’ characteristics and response to treatment.
New study identifies an essential role of a lipid enzyme for the integrity of mitochondria-associated membranes
DEGS1 also appears as a main actor of mitochondrial function, which may have implications for the management of diseases caused by lipid imbalance.
Kickoff to the XarSMART initiative, which aims to promote the transfer of medical technology in Catalonia
This is a proposal coordinated by IDIBELL and financed by AGAUR in which 13 other institutions participate. XarSMART will offer projects access to experts in regulatory, eHealth, data science and precision medicine.
A bioinformatics program will accelerate the diagnosis of hereditary cancer
Bioinformaticians from the Bellvitge Biomedical Research Institute (IDIBELL) and geneticists from the Molecular Diagnostic Laboratory of the Catalan Institute of Oncology (ICO) joined forces to develop a program that facilitates genetic variants classification, as it collects and combines the available information to offer a first classification of the variants.
Bellvitge Hospital and IDIBELL lead clinical trial to reduce the impact of infections in heart transplant patients
It is a project that delves into personalized medicine. This trial has been financed by the Carlos III Health Institute through R&D projects call in 2019, and by a grant from the Spanish Society of Cardiology.
Bellvitge Hospital and IDIBELL successfully test a new method to compare two multiple sclerosis treatments
The study compares the use of two drugs through what they have called a natural experiment, which opens the doors to a new research methodology to compare highly effective treatments, minimizing possible biases in the analysis of the different groups.